Clark Eliana (CIK 0001914448)

Latest company ownership

NTLA - Intellia Therapeutics, Inc.

Role: EVP, Chief Technical Officer

Shares held

95,369

Last filed at

Jul 3, 2025

Confidence Score

45.9

2025Q4

Confidence Score History

2022Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jul 1, 2025	Jul 3, 2025	Intellia Therapeutics, Inc.	EVP, Chief Technical Officer	Sell	26.3	-1,022	-1.06%	✗	$10K
Mar 1, 2025	Mar 4, 2025	Intellia Therapeutics, Inc.	EVP, Chief Technical Officer	Sell	90.0	+31,321	48.90%	✗	$6.1K
Jan 2, 2025	Jan 6, 2025	Intellia Therapeutics, Inc.	EVP, Chief Technical Officer	Sell	42.5	-7,978	-11.08%	✗	$97.1K
Jul 1, 2024	Jul 3, 2024	Intellia Therapeutics, Inc.	EVP, Chief Technical Officer	Sell	37.5	-405	-0.56%	✗	$9.3K
Mar 1, 2024	Mar 5, 2024	Intellia Therapeutics, Inc.	EVP, Chief Technical Officer	Sell	91.3	+30,625	74.98%	✗	$20K
Jan 3, 2024	Jan 5, 2024	Intellia Therapeutics, Inc.	EVP, Chief Technical Officer	Sell	42.5	-4,608	-10.14%	✗	$136K
Jul 3, 2023	Jul 6, 2023	Intellia Therapeutics, Inc.	EVP, Chief Technical Officer	Sell	36.3	-360	-0.79%	✗	$14.6K
Jun 20, 2023	Jun 22, 2023	Intellia Therapeutics, Inc.	EVP, Chief Technical Officer	Sell	28.8	-5,000	-9.97%	✓	$225K
Jul 1, 2022	Jan 6, 2023	Intellia Therapeutics, Inc.	EVP, Chief Technical Officer	Sell	42.5	-2,028	-4.15%	✗	$76.4K